Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography

Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography

  • January 2019 •
  • 150 pages •
  • Report ID: 5751930 •
  • Format: PDF
The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025.
The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period.As per World health organization in 2016, 13% of the world population (adults) were obese.

According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity.However, the strict government guidelines is the major concern in the human microbiome market.

The strict government guidelines are intended to hamper the market to an extent.The advancements in science and technology made the scientists excited about the potential and potency of fecal matter and the microbes in it.

The cell-based therapies found a novel paradigm in drug development, a regulatory framework that reports safety and bio containment issues should be established to minimize adverse events and environmental release of engineered organisms. In recent years, for drug discovery the microbiota plays an important role in the efficacy of therapeutic compounds. There is a new phenomenon in the globe. It is the human gut microbiome and the role it may play in the future of human health. Recently various reports have indicated that the human gut microbiome may be implicated in health conditions such as obesity, metabolism, diabetes, immunity and autism.
The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements.In 2017, the probiotics segment held the largest share of the market, by product.

However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.
The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics.In 2017, therapeutics segment held the largest share of the market, by application.

Moreover, the therapeutics segment is expected to grow at the fastest rate during the coming years owing to the increase in digestive problems, increase in the drug-related side effects, and development of therapies for chronic diseases like cancer.
Some of the major primary and secondary sources included in the report for the human microbiome market are National Cancer Institute, National Health Service, World Health Organization, Food and Drug Administration, Public Health England, and Health Protection Agency among others.

Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.